METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY Read more about METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY US Application 62/992,701Filed on 2020-03-20
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION US Application 62/975,544Filed on 2020-02-12
RAB13 AND NET1 ANTISENSE OLIGONUCLEOTIDES TO TREAT METASTATIC CANCER Read more about RAB13 AND NET1 ANTISENSE OLIGONUCLEOTIDES TO TREAT METASTATIC CANCER US Application 62/966,204Filed on 2020-01-27
INHIBITION OF ACTIVE TUMOR DEFENSE TO IMPROVE IMMUNOTHERAPY EFFICACY AND USES THEREOF Read more about INHIBITION OF ACTIVE TUMOR DEFENSE TO IMPROVE IMMUNOTHERAPY EFFICACY AND USES THEREOF US Application 62/956,955Filed on 2020-01-03
CODEFACS AND LIRICS PIPELINES FOR BULK EXPRESSION DECONVOLUTION Read more about CODEFACS AND LIRICS PIPELINES FOR BULK EXPRESSION DECONVOLUTION US Application 62/940,755Filed on 2019-11-26
KRAS Peptide Vaccine Compositions And Method Of Use Read more about KRAS Peptide Vaccine Compositions And Method Of Use US Application 62/454,270Filed on 2017-02-03
Altering The Humoral Immune Hierarchy Read more about Altering The Humoral Immune Hierarchy US Application 62/935,016Filed on 2019-11-13
ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE Read more about ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE US Application 62/963,959Filed on 2020-01-21
ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF Read more about ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF US Application 62/947,135Filed on 2019-12-12
Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand Read more about Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand US Application 62/820,604Filed on 2019-03-19